130 related articles for article (PubMed ID: 20592713)
1. Adenosine A1 receptor antagonists in clinical research and development.
Hocher B
Kidney Int; 2010 Sep; 78(5):438-45. PubMed ID: 20592713
[TBL] [Abstract][Full Text] [Related]
2. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study.
Gottlieb SS; Givertz MM; Metra M; Gergich K; Bird S; Jones-Burton C; Massie B; Cotter G; Ponikowski P; Weatherley B; O'Connor C; Dittrich H
J Card Fail; 2010 Sep; 16(9):714-9. PubMed ID: 20797594
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine antagonism in the cardiorenal syndrome.
Dohadwala MM; Givertz MM
Cardiovasc Ther; 2008; 26(4):276-86. PubMed ID: 19035879
[TBL] [Abstract][Full Text] [Related]
4. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
5. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
[TBL] [Abstract][Full Text] [Related]
6. Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure.
Ensor CR; Russell SD
Expert Opin Pharmacother; 2010 Oct; 11(14):2405-15. PubMed ID: 20807184
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A1 receptor antagonists and the kidney.
Modlinger PS; Welch WJ
Curr Opin Nephrol Hypertens; 2003 Sep; 12(5):497-502. PubMed ID: 12920396
[TBL] [Abstract][Full Text] [Related]
8. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
[TBL] [Abstract][Full Text] [Related]
9. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
[TBL] [Abstract][Full Text] [Related]
10. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo.
Lee HT; Jan M; Bae SC; Joo JD; Goubaeva FR; Yang J; Kim M
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1367-75. PubMed ID: 16418301
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of adenosine A1-receptor antagonists in congestive heart failure.
Gottlieb SS
Drugs; 2001; 61(10):1387-93. PubMed ID: 11558828
[TBL] [Abstract][Full Text] [Related]
12. The challenge of treating congestion in advanced heart failure.
Bonios MJ; Terrovitis JV; Kaldara E; Ntalianis A; Nanas JN
Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1181-91. PubMed ID: 21932961
[TBL] [Abstract][Full Text] [Related]
13. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
[TBL] [Abstract][Full Text] [Related]
14. Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure.
Shah RH; Frishman WH
Cardiol Rev; 2009; 17(3):125-31. PubMed ID: 19384086
[TBL] [Abstract][Full Text] [Related]
15. Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats.
Hocher B; Heiden S; von Websky K; Arafat AM; Rahnenführer J; Alter M; Kalk P; Ziegler D; Fischer Y; Pfab T
PLoS One; 2011 Mar; 6(3):e17891. PubMed ID: 21423778
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A1 receptor antagonists at a fork in the road.
Givertz MM
Circ Heart Fail; 2009 Nov; 2(6):519-22. PubMed ID: 19919975
[No Abstract] [Full Text] [Related]
17. Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure.
Slawsky MT; Givertz MM
Expert Opin Pharmacother; 2009 Feb; 10(2):311-22. PubMed ID: 19236201
[TBL] [Abstract][Full Text] [Related]
18. Renal function trajectories and clinical outcomes in acute heart failure.
Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA
Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A1 antagonists and the cardiorenal syndrome.
Gottlieb SS
Curr Heart Fail Rep; 2008 Jun; 5(2):105-9. PubMed ID: 18765081
[TBL] [Abstract][Full Text] [Related]
20. BG-9928 (Biogen Idec).
Doggrell SA
Curr Opin Investig Drugs; 2005 Sep; 6(9):962-8. PubMed ID: 16187697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
